180 related articles for article (PubMed ID: 26530986)
1. The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction.
Sonntag M; König HH; Konnopka A
Health Qual Life Outcomes; 2015 Jul; 13():114. PubMed ID: 26530986
[TBL] [Abstract][Full Text] [Related]
2. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
Günther OH; Roick C; Angermeyer MC; König HH
J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
[TBL] [Abstract][Full Text] [Related]
3. Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.
Stark RG; Reitmeir P; Leidl R; König HH
Inflamm Bowel Dis; 2010 Jan; 16(1):42-51. PubMed ID: 19475674
[TBL] [Abstract][Full Text] [Related]
4. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
König HH; Roick C; Angermeyer MC
Eur Psychiatry; 2007 Apr; 22(3):177-87. PubMed ID: 17142014
[TBL] [Abstract][Full Text] [Related]
5. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
6. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Günther O; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of EQ-5D utility indices in alcohol-dependent patients.
Günther OH; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2008 Jan; 92(1-3):291-5. PubMed ID: 17888587
[TBL] [Abstract][Full Text] [Related]
8. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders.
König HH; Born A; Günther O; Matschinger H; Heinrich S; Riedel-Heller SG; Angermeyer MC; Roick C
Health Qual Life Outcomes; 2010 May; 8():47. PubMed ID: 20444251
[TBL] [Abstract][Full Text] [Related]
9. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation.
Chen P; Lin KC; Liing RJ; Wu CY; Chen CL; Chang KC
Qual Life Res; 2016 Jun; 25(6):1585-96. PubMed ID: 26714699
[TBL] [Abstract][Full Text] [Related]
10. Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.
König HH; Günther OH; Angermeyer MC; Roick C
Pharmacoeconomics; 2009; 27(5):405-19. PubMed ID: 19586078
[TBL] [Abstract][Full Text] [Related]
11. Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM; Martin ML; Ricci JF; Bracco A
Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness.
Lin DY; Cheok TS; Kaambwa B; Samson AJ; Morrison C; Chan T; Kroon HM; Jaarsma RL
Health Qual Life Outcomes; 2023 May; 21(1):41. PubMed ID: 37165364
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam.
Mukuria C; Young T; Keetharuth A; Borghs S; Brazier J
Qual Life Res; 2017 Mar; 26(3):749-759. PubMed ID: 28004320
[TBL] [Abstract][Full Text] [Related]
15. [Measuring preferences for depressive health states].
König HH; Bernert S; Angermeyer MC
Psychiatr Prax; 2005 Apr; 32(3):122-31. PubMed ID: 15818528
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety.
Sandin K; Shields G; Gjengedal RGH; Osnes K; Bjørndal MT; Reme SE; Hjemdal O
Health Qual Life Outcomes; 2023 Apr; 21(1):35. PubMed ID: 37061712
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study.
Hu X; Jing M; Zhang M; Yang P; Yan X
Health Qual Life Outcomes; 2020 Oct; 18(1):324. PubMed ID: 33008423
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
19. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.
McClure NS; Sayah FA; Ohinmaa A; Johnson JA
Value Health; 2018 Sep; 21(9):1090-1097. PubMed ID: 30224114
[TBL] [Abstract][Full Text] [Related]
20. Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
Luo N; Cheung YB; Ng R; Lee CF
Health Qual Life Outcomes; 2015 Oct; 13():166. PubMed ID: 26438167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
